Chemed (CHE) Change in Receivables (2009 - 2026)

Chemed has reported Change in Receivables for 18 years, with the latest figure at -$26.2 million in Q2 2026.

• Change in Receivables for Q2 2026 came in at -$26.2 million, up 51.48% year-over-year; the trailing twelve-month figure through Jun 2026 was $4.8 million (up 1224.04% YoY), and the FY2025 annual result was $11.6 million, up 208.6% from the prior year.
• Change in Receivables slipped to -$26.2 million in Q2 2026, from $32.9 million in the prior quarter.
• Over five years, Change in Receivables peaked at $67.4 million in Q1 2025 and troughed at -$54.0 million in Q2 2025.
• A 5-year average of $2.9 million and a median of $9.8 million in 2024 frame the typical range for Change in Receivables.
• The largest YoY upside for Change in Receivables was 1361.44% in 2025 against a maximum downside of 794.71% in 2025.
• A 5-year view of Change in Receivables shows it stood at $18.6 million in 2022, then decreased by 26.56% to $13.6 million in 2023, then slumped by 283.32% to -$25.0 million in 2024, then slumped by 31.15% to -$32.8 million in 2025, then climbed by 20.19% to -$26.2 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were -$26.2 million in Q2 2026, $32.9 million in Q1 2026, and -$32.8 million in Q4 2025.